Back

Association of the non–lipoprotein(a) apolipoprotein b–to–lipoprotein(a) ratio with renal dysfunction in cardiovascular disease patients: implications for atherosclerotic burden and prognosis

31 August 2026 (13:45 - 13:55)
Organised by: Logo
Congress Presentation Part of: Advanced cardiorenal disease in clinical practice: implementation, interventions, and prognosis Renal Failure and Cardiovascular Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Kinuko Yamamoto

(Japan)

5 More presentations in this session

Presentation thumbnail
Cardiorenal syndrome in German primary care: real-world diagnostics and SGLT2 Inhibitor use
Associate Professor S. Wassmann (Munich, DE)
Abstract
Presentation thumbnail
PEN2 stabilizes SLC25A51 to inhibit vascular calcification through NAD+ redistribution between mitochondrion and nucleus
Assistant Professor B. Dong (CN)
Abstract
Presentation thumbnail
Effects on albuminuria and blood pressure after radiofrequency renal denervation: two-year results from the Global SYMPLICITY Registry DEFINE
Professor M. Schlaich (Perth, AU)
Abstract
Presentation thumbnail
Nationwide 5-year outcomes in U.S. dialysis patients with failed bioprosthetic surgical AVR: valve-in-valve TAVR versus redo surgery
Doctor M. Tagliafierro (New York, US)
Abstract
Presentation thumbnail
Clinical profile and determinants of NECPAL positivity in advanced cardiorenal syndrome: a prospective multicentre study
Doctor I. Navarro-Pelayo Torres (Granada, ES)
Abstract

Access the full session

Session thumbnail
Advanced cardiorenal disease in clinical practice: implementation, interventions, and prognosis

The Event

Event poster

ESC Congress 2026

31 August 2026 13:45 CET
You may be interested in
thumbnail
Congress Presentation
Association between lipoprotein (a) level and chronic cardio-renal syndrome in patients with coronary artery disease
29 June 2021
thumbnail
Congress Presentation
Apolipoprotein B/apolipoprotein A-I ratio is comparable with C-reactive protein in predicting cancer mortality: results from two multi-ethnic US populations.
1 September 2019
thumbnail
Congress Presentation
The association between non-Lp(a)-ApoB / Lp(a) ratio and plaque vulnerability according to lipid oxidation status
29 August 2026
thumbnail
Congress Presentation
Discordance between LDL cholesterol and apolypoprotein B. Which to prefer to guide treatment?
13 April 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources